top of page
84770f_68a07779fe514e93b3876e8ff37f34c4~mv2_edited.png

ASX:BMT

Beamtree Holdings Ltd

Investment Summary

The fund managers believe Beamtree Holdings Ltd is a promising investment opportunity due to its positioning as a fast-growing global healthcare technology provider with software deployed in over 20 countries. They noted the company’s renewed investor interest attributed to its outstanding underlying results. Notably, Chairperson Emma Gray’s recent acquisition of 20m shares further reflects confidence, increasing her ownership to 10.7% of the company. In their opinion, the guidance for $60m in annual recurring revenue by FY25, showing a 38% compound annual growth from FY23, is an attractive prospect. However, they acknowledged that the announcement of CEO Tim Kelsey stepping down in March 2025 introduced volatility, leading to a -27% performance drag. Despite this, concerns regarding financial stability were mitigated with the FY25 Q1 Trading Update, revealing a 20% revenue growth and reaffirming the target for $60m ARR by the end of 2026.

feedback.png

Commentary From The Managers

Cyan Investment Management

31 Oct 2024

$0.23

  • Cyan Investment Management continues to monitor developments regarding Beamtree Holdings Ltd.
  • The performance drag was attributed to CEO Tim Kelsey's announcement of his departure in March 2025, leading to a decline of -27% in share value.
  • Concerns about Beamtree's financial outlook were addressed with their FY25 Q1 Trading Update.
  • The trading update showed a revenue growth of +20% for FY25.
  • Beamtree confirmed a longer-term target of $60 million ARR by the end of 2026, with $25.5 million as of June 24.

Cyan Investment Management

31 May 2024

$0.23

  • Beamtree is a fast-growing global healthcare technology provider with software deployed in more than 20 countries.
  • Outstanding underlying results have renewed investor interest.
  • Company Chairperson Emma Gray increased her investment in May, acquiring 20m shares, raising her ownership to 10.7% of BMT.
  • Beamtree has guided to $60m in annual recurring revenue by FY25, indicating compound annual revenue growth of 38% from FY23 base.
  • Cyan Investment Management continues to hold its position in Beamtree due to these positive developments.

Please note: The completeness, accuracy or current status of the investments referenced are not guaranteed. 

Subscribe

Join the email list for updates.

Thanks for submitting!

Thesis-Tracker.com aggregates insights from financial services professionals exclusively for informational and educational purposes. Thesis-Tracker.com does not publish proprietary opinions nor does Thesis-Tracker.com enter into commercial arrangements with any of the featured financial services professionals. Before making a decision please consider these and any relevant Product Disclosure Statement. Any advice on this site is general in nature and does not take into consideration your objectives, financial situation or needs.

bottom of page